The group also voted 8-1 that /*Pfizer*/'s Geodon is safe for children and adolescents with bipolar disorder, though nine panelists abstained, complaining of incomplete data from the company.
The group also is weighing expanded approval of Eli Lilly's Zyprexa.
All three drugs already are approved for adults with schizophrenia and bipolar disorder.
The FDA is not required to follow the group's advice, though it usually does.
Get Action News on your website
